Evidence map›Paper›PMID 23166695›Full record

ArticlePloS one2012

Imaging mass spectrometry visualizes ceramides and the pathogenesis of dorfman-chanarin syndrome due to ceramide metabolic abnormality in the skin.

Naoko Goto-Inoue, Takahiro Hayasaka, Nobuhiro Zaima, Kimiko Nakajima, Walter M Holleran, Shigetoshi Sano, Yoshikazu Uchida, Mitsutoshi Setou

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Naoko Goto-InoueDepartment of Cell Biology and Anatomy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, Japan.
Takahiro Hayasaka
Nobuhiro Zaima
Kimiko Nakajima
Walter M Holleran
Shigetoshi Sano
Yoshikazu Uchida
Mitsutoshi Setou
Hamamatsu University School of Medicine · JPKōchi University · JPKindai University · JPNorthern California Institute for Research and Education · USUniversity of California, San Francisco · US

Funding

S1P-Mediated Stimulation of Antimicrobial DefenseR01AR062025 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI HOLLERAN, WALTER M · 2012 to 2016
$1.6M
Epidermal Mechanisms Opposing Ceramide-Induced ApoptosisR01AR051077 · NIAMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI UCHIDA, YOSHIKAZU · 2005 to 2009
$1.5M
NIAMS NIH HHS AR051077NIAMS NIH HHS AR062025NIAMS NIH HHS R01 AR051077NIAMS NIH HHS R01 AR062025
6 · The paper itself

Abstract

Imaging mass spectrometry (IMS) is a useful cutting edge technology used to investigate the distribution of biomolecules such as drugs and metabolites, as well as to identify molecular species in tissues and cells without labeling. To protect against excess water loss that is essential for survival in a terrestrial environment, mammalian skin possesses a competent permeability barrier in the stratum corneum (SC), the outermost layer of the epidermis. The key lipids constituting this barrier in the SC are the ceramides (Cers) comprising of a heterogeneous molecular species. Alterations in Cer composition have been reported in several skin diseases that display abnormalities in the epidermal permeability barrier function. Not only the amounts of different Cers, but also their localizations are critical for the barrier function. We have employed our new imaging system, capable of high-lateral-resolution IMS with an atmospheric-pressure ionization source, to directly visualize the distribution of Cers. Moreover, we show an ichthyotic disease pathogenesis due to abnormal Cer metabolism in Dorfman-Chanarin syndrome, a neutral lipid storage disorder with ichthyosis in human skin, demonstrating that IMS is a novel diagnostic approach for assessing lipid abnormalities in clinical setting, as well as for investigating physiological roles of lipids in cells/tissues.

Indexed as

Diagnostic ImagingMass SpectrometryAnimalsCeramidesHumansIchthyosiform Erythroderma, CongenitalIonsLipid Metabolism, Inborn ErrorsLipidsMiceMolecular ImagingMuscular DiseasesPhosphatidylcholinesPhosphoric Monoester HydrolasesSkinceramide-1-phosphate phosphataseCeramidesIonsLipidsPhosphatidylcholinesPhosphoric Monoester Hydrolases

Identifiers

PMID23166695
PMCPMC3499467
OpenAlexW1995815456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.